deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02611687

Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period

Double Blind, Multicentre, Randomized, Placebo-controlled Trial to Evaluate Safety and Efficacy of Pitolisant in Children From 6 to Less Than 18 Years With Narcolepsy With/Without Cataplexy, Followed by a Prolonged Open-label Period

Sponsor: Bioprojet

Updated 16 times since 2017 Last updated: Jun 18, 2025 Started: Jun 6, 2016 Primary completion: Apr 3, 2021 Completion: Jun 5, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Narcolepsy With Cataplexy and Narcolepsy Without Cataplexy, this trial is completed. The trial is conducted by Bioprojet and has accumulated 16 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshot~Dec 2018 – ~Aug 2020 · 20 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Feb 2022 · 2 months · monthly snapshot~Feb 2022 – ~Mar 2023 · 13 months · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Nov 2024 · 31 days · monthly snapshot~Nov 2024 – ~Jul 2025 · 8 months · monthly snapshot~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

16 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Jul 2025 — Sep 2025 [monthly]

    Completed PHASE3

    Status: Active Not RecruitingCompleted

  3. Nov 2024 — Jul 2025 [monthly]

    Active Not Recruiting PHASE3

  4. Oct 2024 — Nov 2024 [monthly]

    Active Not Recruiting PHASE3

  5. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting PHASE3

Show 11 earlier versions
  1. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE3

  2. Mar 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

  3. Feb 2022 — Mar 2023 [monthly]

    Active Not Recruiting PHASE3

  4. Dec 2021 — Feb 2022 [monthly]

    Active Not Recruiting PHASE3

    Phase: PHASE2PHASE3

  5. Jan 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE2

  6. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

    Status: RecruitingActive Not Recruiting

  7. Dec 2018 — Aug 2020 [monthly]

    Recruiting PHASE2

  8. Aug 2018 — Dec 2018 [monthly]

    Recruiting PHASE2

  9. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE2

  10. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  11. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bioprojet
Data source: Bioprojet

For direct contact, visit the study record on ClinicalTrials.gov .